Happy New Year to all our subscribers!

We are looking forward to another fast-paced year in the medical device world, keeping you up-to-date on all the latest news and information through your subscription to our newsletters.

We know this time of year is when we all look at trimming our inbox, so if you no longer wish to receive our mailing, click unsubscribe at the bottom of this page. If you change your mind, you can resubscribe at anytime by visiting our website.

Contact form

MDCG Guidance: 2021 was a busy year

Last year, several new guidance documents were published by the Medical Devices Coordination Group (MDCG) – a European Commission body that deals with key issues concerning the medical device and IVD sector – from oversight of Notified Bodies, to new technologies and clinical investigations. Here are a few key highlights:

 

Classification (MDCG 2021-24)

In October, MDCG published their guide to Medical Device classification for the EU MDR. This guidance document will prove highly valuable as the risk-based classification of devices directly relates to the relevant routes to compliance for manufacturers.

 

Clinical Investigation (MDCG 2021-28/ -20/ -8/ -6)

Over 2021, the MDCG has released four significant documents relating to the application and review process for clinical investigations. Clinical investigations are one of the most time consuming and resource intensive activities that manufacturers face. In these documents MDCG provides information regarding the clinical investigation application/notification submission process and instructions to assist with clinical investigation identifiers (CIV-ID)

 

EUDAMED (MDCG 2021-13 & MDCG 2021-1)

The European Union Medical Device database (EUDAMED) has so far gone live with three of six intended modules. MDCG guidance highlighting administrative practices and alternative solutions to employ with regard to EUDAMED during this transition phase is of particular help. In addition, the EUDAMED Q&A is a useful tool to understand the registration rules, etc.

All of the MDCG Guidance documents can be found here.

UPCOMING EVENT

Join Psephos and SEHTA online for an online briefing webinar covering key regulatory topics for medical devices in 

Digital Health, AI and IVD technology. (Free of charge)

More information can be found on the events section of our website.

New Swiss Regulations

Many of you will have read about the change in the relationship between Switzerland and the EU in May 2021.

 

As a result, medical device manufacturers must now appoint a Swiss Authorised Representative (CH-REP) to be able to supply the Swiss market.

 

Psephos currently acts as UK Responsible Person and EU Authorised Representative for many clients and we would be happy to discuss your future needs. You can find further information on our website.

Visit our website  
This email was created with Wix.‌ Discover More